Quantcast

Latest Alere Inc. Stories

2014-10-01 08:31:40

The U.S. Department of Health and Human Services will fund up to $12.9 million for the development of Alere's next-generation POC molecular influenza test WALTHAM, Mass., Oct. 1, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostics, today announced that it has entered into a contract with the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) to develop diagnostic...

2014-09-23 12:30:51

100,000 HIV/Syphilis Duo Rapid Tests Donated to African First Ladies to Launch OAFLA's Push to Eliminate Mother-to-Child Transmission of HIV and Syphilis in Their Countries NEW YORK, Sept. 23, 2014 /PRNewswire/ -- Representatives from the Organisation of African First Ladies Against HIV/AIDS, UNAIDS, the International Planned Parenthood Federation (IPPF) and Alere (NYSE: ALR), the world leader in rapid HIV screening and diagnostics products, today called for intensified efforts to...

2014-09-19 08:26:21

WALTHAM, Mass., Sept. 19, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, issued the following statement today in support of President Barack Obama's Executive Order Combating Antibiotic-Resistant Bacteria. "As the global leader in rapid diagnostics for infectious disease, we commend the President for establishing a national strategy to address the serious threat of antibiotic resistance. We look forward to continuing to work with the Administration...

2014-09-15 20:22:03

WALTHAM, Mass., Sept. 15, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere"), a global leader in infectious disease, toxicology, cardiology and diabetes products and services, today confirmed that a group of former executives, led by former CEO Ron Zwanziger, filed a Schedule 13D with the Securities and Exchange Commission and subsequently sent a letter to Gregg J. Powers, Chairman of the Board, requesting one month of due diligence in an effort to secure financing...

2014-09-15 08:29:19

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cardiac POC Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Cardiac POC is a medical test performed near to the site of the patient. The Cardiac POCs are simple medical blood tests that include cholesterol and coagulation testing. Cardiac POC tests include Troponin and brain natriuretic peptide tests, which are used to diagnose cardiovascular...

2014-09-02 20:24:43

WALTHAM, Mass., Sept. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on October 15, 2014 to holders of record of Series B stock at the close of business on October 1, 2014. Such payment will cover the amount of all dividends accrued from July 1, 2014 through...

2014-08-08 08:26:14

WALTHAM, Mass., Aug. 8, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, announced today that it will attend the Canaccord Genuity 34(th) Annual Growth Conference to be held on August 13-14, 2014 at the InterContinental Hotel in Boston. Jon Russell, Vice President, Finance, will attend the conference. Mr. Russell's presentation is scheduled for Wednesday, August 13, at 10:00 am ET. About Alere Alere's global leading rapid diagnostic products and...

2014-08-04 08:27:18

WALTHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today announced its financial results for the quarter ended June 30, 2014. Namal Nawana, Interim Chief Executive Officer and Chief Operating Officer of Alere said, "The second quarter was a period of significant transition for Alere. With the recently announced change in leadership, we are now narrowing our focus on our global leading rapid diagnostic...

2014-07-28 12:28:16

DALLAS, July 28, 2014 /PRNewswire/ -- The In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017 research report says global industry is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017. The global in vitro diagnostics market...

2014-07-25 12:25:08

WALTHAM, Mass., July 25, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today announced that it will release its second quarter 2014 earnings on Monday, August 4, 2014. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related